United Therapeutics (UTHR) Fair Value & DCF

UTHR$597.14+8.53 +1.45%
BiotechnologyLarge CapHigh Quality
Compare
Market cap$25.43BEnterprise value$24.91BRevenue (TTM)$3.19BMarket positionTop 25%

Score

50
Neutral
Value
26
Quality
84
Growth
40

United Therapeutics Corporation (UTHR) trades at $597.14 on $25.43B of equity value, with a trailing P/E of 20.37. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

United Therapeutics (UTHR) Fair Value & DCF

UTHR price $597.14 +8.53 +1.45%

Ticker
UTHR
Price
$597.14
Change
+8.53 +1.45%
Market cap
$25.43B
P/E
20.37
Forward P/E
24.34
Dividend yield
0.00%
Beta
0.56
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
50
Value
26
Quality
84
Growth
40

Stocklytics score rationale: value 26, quality 84, growth 40.

AI Score 75. United Therapeutics Corporation has a strong market cap of $26.1 billion and a solid net profit margin of 38.6%, indicating effective cost management. However, its high price-to-earnings ratio of approximately 21.3 and a price-to-sales ratio of 8.2 suggest that the stock may be overvalued relative to its earnings and sales growth potential

Insights · Forecast · Financials · Learn

Stocklytics home · Screener